NCT06998758View on ClinicalTrials.gov

Megestrol Acetate in Improving Neoadjuvant Chemotherapy-Related Weight Loss in Locally Advanced CRC

PHASE3Not yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 10, 2025

Primary Completion Date

May 10, 2027

Study Completion Date

December 31, 2028

Conditions
Neoadjuvant ChemotherapyWeight Loss
Interventions
DRUG

Megestrol Acetate

Oral megestrol acetate at 625 mg/day is given from the beginning to the end of neoadjuvant chemotherapy.

Trial Locations (1)

510065

The Sixth Affiliated Hospital of Sun-Yat sen University, Guangzhou

All Listed Sponsors
lead

Sixth Affiliated Hospital, Sun Yat-sen University

OTHER